Abstract
Cardiac imaging has a pivotal role in the prevention, diagnosis and treatment of ischaemic heart disease. SPECT is most commonly used for clinical myocardial perfusion imaging, whereas PET is the clinical reference standard for the quantification of myocardial perfusion. MRI does not involve exposure to ionizing radiation, similar to echocardiography, which can be performed at the bedside. CT perfusion imaging is not frequently used but CT offers coronary angiography data, and invasive catheter-based methods can measure coronary flow and pressure. Technical improvements to the quantification of pathophysiological parameters of myocardial ischaemia can be achieved. Clinical consensus recommendations on the appropriateness of each technique were derived following a European quantitative cardiac imaging meeting and using a real-time Delphi process. SPECT using new detectors allows the quantification of myocardial blood flow and is now also suited to patients with a high BMI. PET is well suited to patients with multivessel disease to confirm or exclude balanced ischaemia. MRI allows the evaluation of patients with complex disease who would benefit from imaging of function and fibrosis in addition to perfusion. Echocardiography remains the preferred technique for assessing ischaemia in bedside situations, whereas CT has the greatest value for combined quantification of stenosis and characterization of atherosclerosis in relation to myocardial ischaemia. In patients with a high probability of needing invasive treatment, invasive coronary flow and pressure measurement is well suited to guide treatment decisions. In this Consensus Statement, we summarize the strengths and weaknesses as well as the future technological potential of each imaging modality.
Introduction: The Shift to Absolute Quantification
Ischaemic heart disease remains a leading cause of global mortality. Historically, clinicians have relied on qualitative "eye-balling" of perfusion images to identify areas of reduced blood flow. However, this approach often fails in complex cases, such as balanced ischaemia, where blood flow is reduced globally across the heart.
This Consensus Statement advocates for a shift toward absolute physiological measurements—specifically Myocardial Blood Flow (MBF) measured in ml/g/min. By moving beyond relative comparisons, quantitative imaging allows for a more precise determination of which patients truly require invasive revascularization, such as stents or bypass surgery.
The Physiological Basis of Perfusion Imaging
To accurately quantify ischaemia, imaging must account for the relationship between coronary perfusion pressure and coronary flow. Under resting conditions, coronary autoregulation maintains a relatively constant flow despite changes in pressure. However, during maximal vasodilation (hyperaemia), this autoregulatory tone is lost, and flow becomes linearly dependent on perfusion pressure. Quantitative imaging aims to measure this maximal flow capacity to identify hemodynamically significant obstructions.
Methods: Reaching Expert Consensus
The framework presented in this paper was developed using a real-time Delphi process. A panel of 20 experts from seven European countries—including cardiologists, radiologists, and nuclear medicine physicians—reviewed technical parameters and clinical scenarios. Through iterative rounds of transparent rating (on a scale of 1–9), the panel established a unified roadmap for the appropriate use of SPECT, PET, MRI, CT, and invasive methods.
Modality-Specific "Sweet Spots"
The consensus identifies specific clinical scenarios where certain modalities excel:
- PET: Considered the clinical reference standard for absolute quantification. It is particularly valuable for patients with multivessel disease to exclude balanced ischaemia.
- MRI: Offers a "one-stop-shop" for patients with complex disease, providing high-resolution data on heart function, fibrosis (scarring), and perfusion without ionizing radiation.
- SPECT: Traditionally limited by lower resolution, SPECT has been revitalized by Cadmium-Zinc-Telluride (CZT) detectors. These allow for absolute MBF quantification, lower radiation doses (<1 mSv), and improved performance in patients with high BMI.
- Cardiac CT: Its primary strength is the ability to combine anatomical data (degree of stenosis) with functional perfusion data in a single examination.
Quantitative analysis across these modalities often relies on tracer kinetic modeling, which tracks the distribution of a contrast agent or radioactive tracer through the coronary tree over time.
Key Results and Clinical Evidence
The consensus synthesized data from landmark trials to provide evidence-based recommendations:
- Diagnostic Accuracy: In head-to-head comparisons (e.g., MR-IMPACT II and CE-MARC), MRI demonstrated superior sensitivity (AUC 0.89) compared to traditional SPECT (AUC 0.74).
- Invasive Gap: While invasive Fractional Flow Reserve (FFR) is a gold standard for guiding treatment in the catheterization lab, it is currently used in less than 6% of patients globally, highlighting a significant gap between clinical guidelines and real-world practice.
- CT Specificity: Perfusion CT has shown higher specificity (86%) than CT-derived FFR (78%) for identifying lesions that cause significant ischaemia.
Limitations and the Future of Imaging
Despite technical advancements, several hurdles remain. There is a lack of uniform "cut-off" values for pathological blood flow across different manufacturers and imaging platforms. Furthermore, high-end tools like $^{15}$O-water PET require expensive on-site cyclotrons, limiting their accessibility.
Looking forward, the integration of Artificial Intelligence (AI) and deep learning is expected to automate complex analysis and reduce image artifacts. Technological leaps such as "baby cyclotrons" for PET and photon-counting detectors for ultra-high-resolution CT promise to make quantitative cardiac imaging a routine component of personalized cardiovascular medicine.
Summary updated